GAMA
KYNB

Graticule Asia Macro Advisors’s Kyntra Bio KYNB Stock Holding History

Graticule Asia Macro Advisors’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-680
Closed -$518K – 115
2015
Q4 		$518K Sell
680
-154
-18% -$102K 0.08% 157
2015
Q3 		$457K Buy
+834
New +$505K 0.05% 75

Other funds holding KYNB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Graticule Asia Macro Advisors's KYNB Position: Q1 2016 in Review

Graticule Asia Macro Advisors sold out of Kyntra Bio (KYNB) in Q1 2016, closing a stake of 680 shares — an estimated $518K sold.

Graticule Asia Macro Advisors first reported a position in KYNB in Q3 2015 and held it in 2 quarters. The position peaked at $518K in Q4 2015. 134 funds tracked by Wall St. Rank hold KYNB as of Q1 2016.

  • Graticule Asia Macro Advisors reported no remaining Kyntra Bio position as of Q1 2016 after selling out during the quarter.
  • Graticule Asia Macro Advisors sold 680 Kyntra Bio shares in Q1 2016, an estimated $518K.
  • Graticule Asia Macro Advisors first reported a position in Kyntra Bio in Q3 2015 and held it in 2 quarters.
  • Graticule Asia Macro Advisors's Kyntra Bio position peaked at $518K in Q4 2015.
  • 134 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2016.

Based on Graticule Asia Macro Advisors's 13F filing for Q1 2016, filed 13 May 2016.